Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All normal donors for patients undergoing allogeneic peripheral blood stem cell (PBSC) for hematologic diseases will be invited to participate in this research trial.~* All patients must meet criteria for transplantation.~* Final eligibility will be determined by the health professionals conducting this clinical trial.~Exclusion Criteria:~* Donors for patients undergoing selected or manipulated PBSC grafts are not eligible.~* Donors who are pregnant or lactating females and donors with a known hypersensitivity to either G-CSF or GM-CSF will be excluded from this study.~* Final eligibility will be determined by the health professionals conducting this clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- G-CSF(Granulocyte Colony-Stimulating Factor ) (Type: ACTIVE_COMPARATOR): Single use of G-CSF(Granulocyte Colony-Stimulating Factor ) G-CSF 7.5 µg/kg twice a day
- Granulocyte CSF+Granulocyte Macrophage CSF (Type: ACTIVE_COMPARATOR): Combined use of G-CSF(Granulocyte Colony-Stimulating Factor ) and GM-CSF (Granulocyte Macrophage Colony Stimulating Factor) (G-CSF 7.5 µg/kg / GM-CSF 7.5 µg/kg.)

Based on this trial design, predict the completion outcome and termination type (if applicable).